Uranium Energy stock holds Buy rating at Stifel despite missed earnings

Uranium Energy Corp (UEC) maintained 'Buy' ratings from Stifel and Goldman Sachs, with price targets of $10.50 and $13.00 respectively, despite reporting lower-than-expected Q4 2025 revenue due to no sales and missing full-year revenue and EPS estimates. The company achieved a significant operational milestone with its first uranium production of 130,000 pounds from Christensen Ranch, which analysts view as a key de-risking event, while its Burke Hollow project remains on schedule for a late 2025 operational start-up. This operational progress and anticipated substantial revenue growth this fiscal year underpin the continued positive outlook for UEC, which has seen its stock gain over 13% recently.

Analysis

Uranium Energy Corp. (UEC) is experiencing a disconnect between its recent financial performance and its operational progress, with investors and analysts prioritizing the latter. The company reported no revenue for fiscal Q4 2025, missing Stifel's $15.6 million forecast due to the timing of uranium sales, and also fell short of full-year revenue and earnings estimates with $66.84 million in revenue and a $0.20 loss per share. Despite these misses, the market sentiment remains positive, reflected in a stock gain of over 13% in the past week. This bullishness is anchored in significant operational achievements, most notably the first-ever uranium production of 130,000 pounds from its Christensen Ranch facility. Analysts at Stifel and Goldman Sachs view this as a pivotal de-risking event, maintaining 'Buy' ratings with price targets of $10.50 and $13.00, respectively. The outlook is further supported by the Burke Hollow project remaining on schedule for a late 2025 start-up and analyst expectations for revenue growth to exceed 337% in the current fiscal year, signaling a transition from a development-stage entity to a functioning producer.

Key Decisions for Investors

• Investors should weigh the recent operational de-risking, evidenced by the first production at Christensen Ranch, more heavily than the backward-looking Q4 revenue miss, which was attributed to sales timing.
• Given the reiterated 'Buy' ratings from Stifel and Goldman Sachs and a forward revenue growth forecast of over 337%, maintaining or adding to positions could be justified for those aligned with the long-term production ramp-up thesis.
• Monitor execution risk closely, particularly the production ramp-up and the on-schedule commissioning of the Burke Hollow project, as any delays could challenge the current bullish sentiment and stock valuation.